Firstly, we must highlight several oncogenic point mutations associated with epigenetic regulators, such as IDH1/2, EZH2 or DNMT3A. Moreover, not all mutations are tumor-prone, and we must consider tumor-suppressive factors such as KDM6A and CREBBP/P300 [227]. The gene discussed is DNMT3A; the disease is neoplasm.